Related Experiment Video
Updated: Jun 3, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Thrombocytopenia in pregnancy
1Division of Hematology/Oncology, University of Michigan Medical Center, University of Michigan, Ann Arbor, MI 48105, USA. pbockens@umich.edu
Thrombocytopenia in pregnancy is most frequently a benign process that does not require intervention. However, 35% of cases of thrombocytopenia in pregnancy are related to disease processes that may have serious bleeding consequences at delivery or for which thrombocytopenia may be an indicator of a more severe systemic disorder requiring emergent maternal and fetal care. Thus, all pregnant women with platelet counts less than 100,000/μL require careful hematological and obstetric consultation to exclude more serious disorders.
Thrombocytopenia in pregnancy is most frequently a benign process that does not require intervention. However, 35% of cases of thrombocytopenia in pregnancy are related to disease processes that may have serious bleeding consequences at delivery or for which thrombocytopenia may be an indicator of a more severe systemic disorder requiring emergent maternal and fetal care. Thus, all pregnant women with platelet counts less than 100,000/μL require careful hematological and obstetric consultation to exclude more serious disorders.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Teratogenicity
Venous Thrombosis I: Introduction